{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:02:34Z","timestamp":1789473754867,"version":"build-2803163510"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12035-024-04506-9","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T03:02:29Z","timestamp":1727319749000},"page":"3813-3832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Multifaceted Role of L-Type Amino Acid Transporter 1 at the Blood\u2013Brain Barrier: Structural Implications and Therapeutic Potential"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-8474","authenticated-orcid":false,"given":"H. Shafeeq","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"issue":"1","key":"4506_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L (2020) A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17(1):69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"4506_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163(5):1064\u20131078. https:\/\/doi.org\/10.1016\/j.cell.2015.10.067","journal-title":"Cell"},{"issue":"1","key":"4506_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2045-8118-8-2","volume":"8","author":"SA Liddelow","year":"2011","unstructured":"Liddelow SA (2011) Fluids and barriers of the CNS: a historical viewpoint. Fluids Barriers CNS 8(1):2. https:\/\/doi.org\/10.1186\/2045-8118-8-2","journal-title":"Fluids Barriers CNS"},{"key":"4506_CR4","unstructured":"Ridley H (1987) The anatomy of the brain. Classics of Neurology & Neurosurgery"},{"issue":"2","key":"4506_CR5","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2012.6.FOCUS12139","volume":"33","author":"JD Thakur","year":"2012","unstructured":"Thakur JD, Sonig A, Chittiboina P, Khan IS, Wadhwa R, Nanda A (2012) Humphrey Ridley (1653\u20131708): 17th century evolution in neuroanatomy and selective cerebrovascular injections for cadaver dissection. Neurosurg Focus 33(2):E3. https:\/\/doi.org\/10.3171\/2012.6.FOCUS12139","journal-title":"Neurosurg Focus"},{"issue":"3","key":"4506_CR6","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/ijms23031898","volume":"23","author":"KL Nilles","year":"2022","unstructured":"Nilles KL, Williams EI, Betterton RD, Davis TP, Ronaldson PT (2022) Blood-brain barrier transporters: opportunities for therapeutic development in ischemic stroke. Int J Mol Sci 23(3):1898. https:\/\/doi.org\/10.3390\/ijms23031898","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4506_CR7","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/pharmaceutics14071501","volume":"14","author":"PT Ronaldson","year":"2022","unstructured":"Ronaldson PT, Davis TP (2022) Transport mechanisms at the blood-brain barrier and in cellular compartments of the neurovascular unit: focus on CNS delivery of small molecule drugs. Pharmaceutics 14(7):1501. https:\/\/doi.org\/10.3390\/pharmaceutics14071501","journal-title":"Pharmaceutics"},{"issue":"36","key":"4506_CR8","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","volume":"273","author":"Y Kanai","year":"1998","unstructured":"Kanai Y, Segawa H, Miyamoto KI, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273(36):23629\u201323632","journal-title":"J Biol Chem"},{"issue":"6699","key":"4506_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/26246","volume":"395","author":"L Mastroberardino","year":"1998","unstructured":"Mastroberardino L, Spindler B, Pfeiffer R et al (1998) Amino-acid transport by heterodimers of 4F2hc\/CD98 and members of a permease family. Nature 395(6699):288\u2013291","journal-title":"Nature"},{"issue":"2","key":"4506_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/bbrc.1999.0206","volume":"255","author":"PD Prasad","year":"1999","unstructured":"Prasad PD, Wang H, Huang W et al (1999) Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 255(2):283\u2013288","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"4506_CR11","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.3390\/ijms21207573","volume":"21","author":"S Kantipudi","year":"2020","unstructured":"Kantipudi S, Jeckelmann JM, Ucurum Z, Bosshart PD, Fotiadis D (2020) The heavy chain 4F2hc modulates the substrate affinity and specificity of the light chains LAT1 and LAT2. Int J Mol Sci 21(20):7573. https:\/\/doi.org\/10.3390\/ijms21207573","journal-title":"Int J Mol Sci"},{"issue":"Pt 7","key":"4506_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1107\/S2059798319009094","volume":"75","author":"GN Chiduza","year":"2019","unstructured":"Chiduza GN, Johnson RM, Wright GSA, Antonyuk SV, Muench SP, Hasnain SS (2019) LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM. Acta Crystallogr D Struct Biol 75(Pt 7):660\u2013669. https:\/\/doi.org\/10.1107\/S2059798319009094","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"4506_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","volume":"67","author":"L Napolitano","year":"2015","unstructured":"Napolitano L, Scalise M, Galluccio M, Pochini L, Albanese LM, Indiveri C (2015) LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter. Int J Biochem Cell Biol 67:25\u201333. https:\/\/doi.org\/10.1016\/j.biocel.2015.08.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"20","key":"4506_CR14","doi-asserted-by":"publisher","first-page":"16877","DOI":"10.1074\/jbc.M008248200","volume":"276","author":"WA Campbell","year":"2001","unstructured":"Campbell WA, Thompson NL (2001) Overexpression of LAT1\/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem 276(20):16877\u201316884. https:\/\/doi.org\/10.1074\/jbc.M008248200","journal-title":"J Biol Chem"},{"issue":"2","key":"4506_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbamem.2005.07.007","volume":"1715","author":"RJ Boado","year":"2005","unstructured":"Boado RJ, Li JY, Chu C, Ogoshi F, Wise P, Pardridge WM (2005) Site-directed mutagenesis of cysteine residues of large neutral amino acid transporter LAT1. Biochim Biophys Acta 1715(2):104\u2013110. https:\/\/doi.org\/10.1016\/j.bbamem.2005.07.007","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"4506_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0014-5793(98)01359-3","volume":"439","author":"R Pfeiffer","year":"1998","unstructured":"Pfeiffer R, Spindler B, Loffing J, Skelly PJ, Shoemaker CB, Verrey F (1998) Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond. FEBS Lett 439(1\u20132):157\u2013162. https:\/\/doi.org\/10.1016\/s0014-5793(98)01359-3","journal-title":"FEBS Lett"},{"issue":"20","key":"4506_CR17","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.3390\/ijms21207573","volume":"21","author":"S Kantipudi","year":"2020","unstructured":"Kantipudi S, Jeckelmann JM, Ucurum Z, Bosshart PD, Fotiadis D (2020) The heavy chain 4F2hc modulates the substrate affinity and specificity of the light chains LAT1 and LAT2. Int J Mol Sci. 21(20):7573. https:\/\/doi.org\/10.3390\/ijms21207573","journal-title":"Int J Mol Sci."},{"issue":"6","key":"4506_CR18","doi-asserted-by":"publisher","first-page":"e0157139","DOI":"10.1371\/journal.pone.0157139","volume":"11","author":"C Papin-Michault","year":"2016","unstructured":"Papin-Michault C, Bonnetaud C, Dufour M et al (2016) Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers. PLoS ONE 11(6):e0157139. https:\/\/doi.org\/10.1371\/journal.pone.0157139","journal-title":"PLoS ONE"},{"issue":"1","key":"4506_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-021-00247-4","volume":"7","author":"R Yan","year":"2021","unstructured":"Yan R, Li Y, M\u00fcller J et al (2021) Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter. Cell Discov 7(1):16. https:\/\/doi.org\/10.1038\/s41421-021-00247-4","journal-title":"Cell Discov"},{"issue":"1","key":"4506_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12987-023-00501-9","volume":"20","author":"B Ozg\u00fcr","year":"2023","unstructured":"Ozg\u00fcr B, Puris E, Brachner A et al (2023) Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. Fluids Barriers CNS 20(1):96. https:\/\/doi.org\/10.1186\/s12987-023-00501-9","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"4506_CR21","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s11095-022-03249-3","volume":"39","author":"T Kurosawa","year":"2022","unstructured":"Kurosawa T, Sako D, Tega Y et al (2022) Construction and functional evaluation of a three-dimensional blood-brain barrier model equipped with human induced pluripotent stem cell-derived brain microvascular endothelial cells. Pharm Res 39(7):1535\u20131547. https:\/\/doi.org\/10.1007\/s11095-022-03249-3","journal-title":"Pharm Res"},{"key":"4506_CR22","doi-asserted-by":"publisher","first-page":"e52204","DOI":"10.3791\/52204","volume":"93","author":"T Ruck","year":"2014","unstructured":"Ruck T, Bittner S, Epping L, Herrmann AM, Meuth SG (2014) Isolation of primary murine brain microvascular endothelial cells. J Vis Exp 93:e52204. https:\/\/doi.org\/10.3791\/52204","journal-title":"J Vis Exp"},{"issue":"1\u20132","key":"4506_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.06.019","volume":"179","author":"C Silwedel","year":"2006","unstructured":"Silwedel C, F\u00f6rster C (2006) Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J Neuroimmunol 179(1\u20132):37\u201345. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.06.019","journal-title":"J Neuroimmunol"},{"key":"4506_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-61779-452-0_28","volume":"814","author":"NJ Abbott","year":"2012","unstructured":"Abbott NJ, Dolman DE, Drndarski S, Fredriksson SM (2012) An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol Biol 814:415\u2013430. https:\/\/doi.org\/10.1007\/978-1-61779-452-0_28","journal-title":"Methods Mol Biol"},{"issue":"3","key":"4506_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0928-0987(00)00123-8","volume":"12","author":"PJ Gaillard","year":"2001","unstructured":"Gaillard PJ, Voorwinden LH, Nielsen JL et al (2001) Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 12(3):215\u2013222. https:\/\/doi.org\/10.1016\/s0928-0987(00)00123-8","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20133","key":"4506_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.regpep.2004.05.023","volume":"123","author":"K Hayashi","year":"2004","unstructured":"Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, Niwa M (2004) Effects of hypoxia on endothelial\/pericytic co-culture model of the blood-brain barrier. Regul Pept 123(1\u20133):77\u201383. https:\/\/doi.org\/10.1016\/j.regpep.2004.05.023","journal-title":"Regul Pept"},{"issue":"8","key":"4506_CR27","doi-asserted-by":"publisher","first-page":"e0134765","DOI":"10.1371\/journal.pone.0134765","volume":"10","author":"LB Thomsen","year":"2015","unstructured":"Thomsen LB, Burkhart A, Moos T (2015) A Triple culture model of the blood-brain barrier using porcine brain endothelial cells, astrocytes and pericytes. PLoS ONE 10(8):e0134765. https:\/\/doi.org\/10.1371\/journal.pone.0134765","journal-title":"PLoS ONE"},{"issue":"2","key":"4506_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jneumeth.2011.05.012","volume":"199","author":"K Hatherell","year":"2011","unstructured":"Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ (2011) Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 199(2):223\u2013229. https:\/\/doi.org\/10.1016\/j.jneumeth.2011.05.012","journal-title":"J Neurosci Methods"},{"issue":"2","key":"4506_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0006-8993(02)03167-0","volume":"951","author":"L Cucullo","year":"2002","unstructured":"Cucullo L, McAllister MS, Kight K et al (2002) A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res 951(2):243\u2013254. https:\/\/doi.org\/10.1016\/s0006-8993(02)03167-0","journal-title":"Brain Res"},{"key":"4506_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2202-14-18","volume":"14","author":"L Cucullo","year":"2013","unstructured":"Cucullo L, Hossain M, Tierney W, Janigro D (2013) A new dynamic in vitro modular capillaries-venules modular system: cerebrovascular physiology in a box. BMC Neurosci 14:18. https:\/\/doi.org\/10.1186\/1471-2202-14-18","journal-title":"BMC Neurosci"},{"key":"4506_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2202-12-40","volume":"12","author":"L Cucullo","year":"2011","unstructured":"Cucullo L, Hossain M, Puvenna V, Marchi N, Janigro D (2011) The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci 12:40. https:\/\/doi.org\/10.1186\/1471-2202-12-40","journal-title":"BMC Neurosci"},{"issue":"10","key":"4506_CR32","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1039\/c2lc40094d","volume":"12","author":"R Booth","year":"2012","unstructured":"Booth R, Kim H (2012) Characterization of a microfluidic in vitro model of the blood-brain barrier (\u03bcBBB). Lab Chip 12(10):1784\u20131792. https:\/\/doi.org\/10.1039\/c2lc40094d","journal-title":"Lab Chip"},{"issue":"1","key":"4506_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/bit.26045","volume":"114","author":"YI Wang","year":"2017","unstructured":"Wang YI, Abaci HE, Shuler ML (2017) Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Biotechnol Bioeng 114(1):184\u2013194. https:\/\/doi.org\/10.1002\/bit.26045","journal-title":"Biotechnol Bioeng"},{"issue":"5","key":"4506_CR34","doi-asserted-by":"publisher","first-page":"054124","DOI":"10.1063\/1.4934713","volume":"9","author":"JA Brown","year":"2015","unstructured":"Brown JA, Pensabene V, Markov DA et al (2015) Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor. Biomicrofluidics. 9(5):054124. https:\/\/doi.org\/10.1063\/1.4934713","journal-title":"Biomicrofluidics."},{"issue":"3","key":"4506_CR35","doi-asserted-by":"publisher","first-page":"e0150360","DOI":"10.1371\/journal.pone.0150360","volume":"11","author":"A Herland","year":"2016","unstructured":"Herland A, van der Meer AD, FitzGerald EA, Park TE, Sleeboom JJ, Ingber DE (2016) Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip. PLoS One. 11(3):e0150360. https:\/\/doi.org\/10.1371\/journal.pone.0150360","journal-title":"PLoS One."},{"key":"4506_CR36","doi-asserted-by":"publisher","first-page":"105577","DOI":"10.1016\/j.ejps.2020.105577","volume":"156","author":"C Goldeman","year":"2021","unstructured":"Goldeman C, Andersen M, Al-Robai A et al (2021) Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5). Eur J Pharm Sci 156:105577. https:\/\/doi.org\/10.1016\/j.ejps.2020.105577","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"4506_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12987-020-00193-5","volume":"17","author":"C Goldeman","year":"2020","unstructured":"Goldeman C, Ozg\u00fcr B, Brodin B (2020) Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells. Fluids Barriers CNS 17(1):32. https:\/\/doi.org\/10.1186\/s12987-020-00193-5","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"4506_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/mp3004308","volume":"10","author":"S Ohtsuki","year":"2013","unstructured":"Ohtsuki S, Ikeda C, Uchida Y et al (2013) Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model. Mol Pharm 10(1):289\u2013296. https:\/\/doi.org\/10.1021\/mp3004308","journal-title":"Mol Pharm"},{"issue":"4","key":"4506_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1203\/01.PDR.0000113461.07950.72","volume":"55","author":"RJ Boado","year":"2004","unstructured":"Boado RJ, Li JY, Pardridge WM (2004) Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein. Pediatr Res 55(4):557\u2013560. https:\/\/doi.org\/10.1203\/01.PDR.0000113461.07950.72","journal-title":"Pediatr Res"},{"issue":"5","key":"4506_CR40","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/acs.molpharmaceut.9b00114","volume":"16","author":"T Masuda","year":"2019","unstructured":"Masuda T, Hoshiyama T, Uemura T et al (2019) Large-scale quantitative comparison of plasma transmembrane proteins between two human blood-brain barrier model cell lines, hCMEC\/D3 and HBMEC\/ci\u03b2. Mol Pharm 16(5):2162\u20132171. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00114","journal-title":"Mol Pharm"},{"issue":"1","key":"4506_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/biores.2019.0026","volume":"8","author":"M Ohshima","year":"2019","unstructured":"Ohshima M, Kamei S, Fushimi H, Mima S, Yamada T, Yamamoto T (2019) Prediction of drug permeability using in vitro blood-brain barrier models with human induced pluripotent stem cell-derived brain microvascular endothelial cells. Biores Open Access 8(1):200\u2013209. https:\/\/doi.org\/10.1089\/biores.2019.0026","journal-title":"Biores Open Access"},{"issue":"2","key":"4506_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida O, Kanai Y, Chairoungdua A et al (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514(2):291\u2013302. https:\/\/doi.org\/10.1016\/s0005-2736(01)00384-4","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4506_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","volume":"20","author":"K Bahrami","year":"2023","unstructured":"Bahrami K, J\u00e4rvinen J, Laitinen T et al (2023) Structural features affecting the interactions and transportability of LAT1-targeted phenylalanine drug conjugates. Mol Pharm 20(1):206\u2013218. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00594","journal-title":"Mol Pharm"},{"issue":"8","key":"4506_CR44","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1021\/acs.jctc.3c01391","volume":"20","author":"K Hutchinson","year":"2024","unstructured":"Hutchinson K, Schlessinger A (2024) Comprehensive characterization of LAT1 cholesterol-binding sites. J Chem Theory Comput 20(8):3349\u20133358. https:\/\/doi.org\/10.1021\/acs.jctc.3c01391","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"4506_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejps.2012.11.014","volume":"48","author":"H Ylikangas","year":"2013","unstructured":"Ylikangas H, Peura L, Malmioja K et al (2013) Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion. Eur J Pharm Sci 48(3):523\u2013531. https:\/\/doi.org\/10.1016\/j.ejps.2012.11.014","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"4506_CR46","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.3390\/ijms24044042","volume":"24","author":"C Brunocilla","year":"2023","unstructured":"Brunocilla C, Console L, Rovella F, Indiveri C (2023) Insights into the transport cycle of LAT1 and interaction with the inhibitor JPH203. Int J Mol Sci 24(4):4042. https:\/\/doi.org\/10.3390\/ijms24044042","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4506_CR47","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.bmcl.2010.04.086","volume":"20","author":"J Matharu","year":"2010","unstructured":"Matharu J, Oki J, Worthen DR, Smith QR, Crooks PA (2010) Regiospecific and conformationally restrained analogs of melphalan and DL-2-NAM-7 and their affinities for the large neutral amino acid transporter (system LAT1) of the blood-brain barrier. Bioorg Med Chem Lett 20(12):3688\u20133691. https:\/\/doi.org\/10.1016\/j.bmcl.2010.04.086","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"4506_CR48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/cmdc.202000824","volume":"16","author":"B Venteicher","year":"2021","unstructured":"Venteicher B, Merklin K, Ngo HX et al (2021) The effects of prodrug size and a carbonyl linker on l-type amino acid transporter 1-targeted cellular and brain uptake. ChemMedChem 16(5):869\u2013880. https:\/\/doi.org\/10.1002\/cmdc.202000824","journal-title":"ChemMedChem"},{"key":"4506_CR49","doi-asserted-by":"publisher","first-page":"118714","DOI":"10.1016\/j.ijpharm.2019.118714","volume":"571","author":"J Huttunen","year":"2019","unstructured":"Huttunen J, Gynther M, Vellonen KS, Huttunen KM (2019) L-type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs). Int J Pharm 571:118714. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118714","journal-title":"Int J Pharm"},{"issue":"18","key":"4506_CR50","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/hmg\/ddaa186","volume":"29","author":"AM Sokolov","year":"2020","unstructured":"Sokolov AM, Holmberg JC, Feliciano DM (2020) The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development. Hum Mol Genet 29(18):3003\u20133013. https:\/\/doi.org\/10.1093\/hmg\/ddaa186","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"4506_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ymgme.2011.07.003","volume":"104","author":"KA Strauss","year":"2011","unstructured":"Strauss KA, Brumbaugh J, Duffy A et al (2011) Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 104(1\u20132):93\u2013106. https:\/\/doi.org\/10.1016\/j.ymgme.2011.07.003","journal-title":"Mol Genet Metab"},{"issue":"7","key":"4506_CR52","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.3390\/ijms23073637","volume":"23","author":"C Bay","year":"2022","unstructured":"Bay C, Bajraktari-Sylejmani G, Haefeli WE, Burhenne J, Weiss J, Sauter M (2022) Functional characterization of the solute carrier LAT-1 (SLC7A5\/SLC2A3) in human brain capillary endothelial cells with rapid UPLC-MS\/MS quantification of intracellular isotopically labelled L-leucine. Int J Mol Sci 23(7):3637. https:\/\/doi.org\/10.3390\/ijms23073637","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4506_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.chembiol.2023.09.008","volume":"31","author":"G Pornnoppadol","year":"2024","unstructured":"Pornnoppadol G, Bond LG, Lucas MJ et al (2024) Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. Cell Chem Biol 31(2):361-372.e8. https:\/\/doi.org\/10.1016\/j.chembiol.2023.09.008","journal-title":"Cell Chem Biol"},{"issue":"21","key":"4506_CR54","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A 96(21):12079\u201312084. https:\/\/doi.org\/10.1073\/pnas.96.21.12079","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4506_CR55","doi-asserted-by":"publisher","first-page":"12860","DOI":"10.1038\/s41598-019-49009-z","volume":"9","author":"J Huttunen","year":"2019","unstructured":"Huttunen J, Peltokangas S, Gynther M et al (2019) L-type amino acid transporter 1 (LAT1\/Lat1)-utilizing prodrugs can improve the delivery of drugs into neurons, astrocytes and microglia. Sci Rep 9(1):12860. https:\/\/doi.org\/10.1038\/s41598-019-49009-z","journal-title":"Sci Rep"},{"issue":"2","key":"4506_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuroscience.2008.06.015","volume":"155","author":"LM Roberts","year":"2008","unstructured":"Roberts LM, Black DS, Raman C et al (2008) Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155(2):423\u2013438. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.06.015","journal-title":"Neuroscience"},{"issue":"4","key":"4506_CR57","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1021\/jm701175d","volume":"51","author":"M Gynther","year":"2008","unstructured":"Gynther M, Laine K, Ropponen J et al (2008) Large neutral amino acid transporter enables brain drug delivery via prodrugs. J Med Chem 51(4):932\u2013936. https:\/\/doi.org\/10.1021\/jm701175d","journal-title":"J Med Chem"},{"issue":"16","key":"4506_CR58","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.1021\/acs.jmedchem.8b01007","volume":"61","author":"HC Chien","year":"2018","unstructured":"Chien HC, Colas C, Finke K et al (2018) Reevaluating the substrate specificity of the L-type amino acid transporter (LAT1). J Med Chem 61(16):7358\u20137373. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01007","journal-title":"J Med Chem"},{"key":"4506_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejps.2014.09.025","volume":"66","author":"J Rautio","year":"2015","unstructured":"Rautio J, K\u00e4rkk\u00e4inen J, Huttunen KM, Gynther M (2015) Amino acid ester prodrugs conjugated to the \u03b1-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1). Eur J Pharm Sci 66:36\u201340. https:\/\/doi.org\/10.1016\/j.ejps.2014.09.025","journal-title":"Eur J Pharm Sci"},{"issue":"16","key":"4506_CR60","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.bmcl.2019.06.033","volume":"29","author":"C Hall","year":"2019","unstructured":"Hall C, Wolfe H, Wells A et al (2019) l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan. Bioorg Med Chem Lett 29(16):2254\u20132258. https:\/\/doi.org\/10.1016\/j.bmcl.2019.06.033","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"4506_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cbf.1455","volume":"26","author":"Y Omidi","year":"2008","unstructured":"Omidi Y, Barar J, Ahmadian S, Heidari HR, Gumbleton M (2008) Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells. Cell Biochem Funct 26(3):381\u2013391. https:\/\/doi.org\/10.1002\/cbf.1455","journal-title":"Cell Biochem Funct"},{"key":"4506_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fphys.2018.00171","volume":"9","author":"M Taslimifar","year":"2018","unstructured":"Taslimifar M, Buoso S, Verrey F, Kurtcuoglu V (2018) Functional polarity of microvascular brain endothelial cells supported by neurovascular unit computational model of large neutral amino acid homeostasis. Front Physiol 9:171. https:\/\/doi.org\/10.3389\/fphys.2018.00171","journal-title":"Front Physiol"},{"issue":"1","key":"4506_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biomedicines9010009","volume":"9","author":"A Gyawali","year":"2020","unstructured":"Gyawali A, Kang YS (2020) Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (TR-BBB) and motor neuron like (NSC-34) cell lines. Biomedicines 9(1):9. https:\/\/doi.org\/10.3390\/biomedicines9010009","journal-title":"Biomedicines"},{"key":"4506_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.colsurfb.2019.01.031","volume":"176","author":"KJ Mintz","year":"2019","unstructured":"Mintz KJ, Mercado G, Zhou Y et al (2019) Tryptophan carbon dots and their ability to cross the blood-brain barrier. Colloids Surf B Biointerfaces 176:488\u2013493. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.01.031","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"7","key":"4506_CR65","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41551-020-0540-y","volume":"4","author":"S Li","year":"2020","unstructured":"Li S, Su W, Wu H et al (2020) Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids. Nat Biomed Eng 4(7):704\u2013716. https:\/\/doi.org\/10.1038\/s41551-020-0540-y","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"4506_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-017-0336-x","volume":"24","author":"KE Lee","year":"2017","unstructured":"Lee KE, Kang YS (2017) Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells). J Biomed Sci 24(1):28. https:\/\/doi.org\/10.1186\/s12929-017-0336-x","journal-title":"J Biomed Sci"},{"key":"4506_CR67","doi-asserted-by":"publisher","first-page":"107560","DOI":"10.1016\/j.neuropharm.2019.03.003","volume":"161","author":"J Albrecht","year":"2019","unstructured":"Albrecht J, Zieli\u0144ska M (2019) Exchange-mode glutamine transport across CNS cell membranes. Neuropharmacology 161:107560. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.003","journal-title":"Neuropharmacology"},{"issue":"11","key":"4506_CR68","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1177\/0271678X15609331","volume":"36","author":"E Dolgodilina","year":"2016","unstructured":"Dolgodilina E, Imobersteg S, Laczko E, Welt T, Verrey F, Makrides V (2016) Brain interstitial fluid glutamine homeostasis is controlled by blood-brain barrier SLC7A5\/LAT1 amino acid transporter. J Cereb Blood Flow Metab 36(11):1929\u20131941. https:\/\/doi.org\/10.1177\/0271678X15609331","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"4506_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/0271678X211039593","volume":"42","author":"M Taslimifar","year":"2022","unstructured":"Taslimifar M, Faltys M, Kurtcuoglu V, Verrey F, Makrides V (2022) Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC\/D3 model reveal potential LAT1, LAT4, B0AT2 and y+LAT1 functional cooperation. J Cereb Blood Flow Metab 42(1):90\u2013103. https:\/\/doi.org\/10.1177\/0271678X211039593","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"4506_CR70","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1080\/21691401.2016.1276919","volume":"45","author":"D Sharma","year":"2017","unstructured":"Sharma D, Singh M, Kumar P, Vikram V, Mishra N (2017) Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer\u2019s disease. Artif Cells Nanomed Biotechnol 45(8):1620\u20131630. https:\/\/doi.org\/10.1080\/21691401.2016.1276919","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"4506_CR71","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/pharmaceutics14112348","volume":"14","author":"M Alonso","year":"2022","unstructured":"Alonso M, Barcia E, Gonz\u00e1lez JF et al (2022) Functionalization of morin-loaded PLGA nanoparticles with phenylalanine dipeptide targeting the brain. Pharmaceutics 14(11):2348. https:\/\/doi.org\/10.3390\/pharmaceutics14112348","journal-title":"Pharmaceutics"},{"issue":"12","key":"4506_CR72","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.3390\/molecules28124776","volume":"28","author":"C Cunha","year":"2023","unstructured":"Cunha C, Marinheiro D, Ferreira BJML, Oliveira H, Daniel-da-Silva AL (2023) Morin hydrate encapsulation and release from mesoporous silica nanoparticles for melanoma therapy. Molecules 28(12):4776. https:\/\/doi.org\/10.3390\/molecules28124776","journal-title":"Molecules"},{"key":"4506_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejps.2019.01.002","volume":"129","author":"E Puris","year":"2019","unstructured":"Puris E, Gynther M, Huttunen J, Auriola S, Huttunen KM (2019) L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery. Eur J Pharm Sci 129:99\u2013109. https:\/\/doi.org\/10.1016\/j.ejps.2019.01.002","journal-title":"Eur J Pharm Sci"},{"key":"4506_CR74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fninf.2018.00031","volume":"12","author":"G Meng","year":"2018","unstructured":"Meng G, Meng X, Ma X et al (2018) Application of ferulic acid for Alzheimer\u2019s disease: combination of text mining and experimental validation. Front Neuroinform 12:31. https:\/\/doi.org\/10.3389\/fninf.2018.00031","journal-title":"Front Neuroinform"},{"key":"4506_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2017.06.023","volume":"261","author":"E Puris","year":"2017","unstructured":"Puris E, Gynther M, Huttunen J, Petsalo A, Huttunen KM (2017) L-type amino acid transporter 1 utilizing prodrugs: how to achieve effective brain delivery and low systemic exposure of drugs. J Control Release 261:93\u2013104. https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.023","journal-title":"J Control Release"},{"issue":"12","key":"4506_CR76","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1002\/cmdc.201402281","volume":"9","author":"H Ylikangas","year":"2014","unstructured":"Ylikangas H, Malmioja K, Peura L et al (2014) Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1). ChemMedChem 9(12):2699\u20132707. https:\/\/doi.org\/10.1002\/cmdc.201402281","journal-title":"ChemMedChem"},{"issue":"1","key":"4506_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11095-018-2546-7","volume":"36","author":"M Gynther","year":"2018","unstructured":"Gynther M, Puris E, Peltokangas S et al (2018) Alzheimer\u2019s disease phenotype or inflammatory insult does not alter function of L-type amino acid transporter 1 in mouse blood-brain barrier and primary astrocytes. Pharm Res 36(1):17. https:\/\/doi.org\/10.1007\/s11095-018-2546-7","journal-title":"Pharm Res"},{"key":"4506_CR78","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.neuropharm.2021.108588","volume":"191","author":"C Taccola","year":"2021","unstructured":"Taccola C, Barneoud P, Cartot-Cotton S et al (2021) Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration. Neuropharmacology 191:108588. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108588","journal-title":"Neuropharmacology"},{"issue":"11","key":"4506_CR79","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med 214(11):3151\u20133169. https:\/\/doi.org\/10.1084\/jem.20171406","journal-title":"J Exp Med"},{"issue":"1","key":"4506_CR80","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I, Saqib F, Mubarak Z et al (2024) Alzheimer\u2019s disease and drug delivery across the blood-brain barrier: approaches and challenges. Eur J Med Res 29(1):313. https:\/\/doi.org\/10.1186\/s40001-024-01915-3","journal-title":"Eur J Med Res"},{"issue":"1","key":"4506_CR81","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1515\/tnsci-2022-0258","volume":"13","author":"KR Mittal","year":"2022","unstructured":"Mittal KR, Pharasi N, Sarna B et al (2022) Nanotechnology-based drug delivery for the treatment of CNS disorders. Transl Neurosci 13(1):527\u2013546. https:\/\/doi.org\/10.1515\/tnsci-2022-0258","journal-title":"Transl Neurosci"},{"issue":"2","key":"4506_CR82","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/pharmaceutics14020224","volume":"14","author":"A Ayub","year":"2022","unstructured":"Ayub A, Wettig S (2022) An overview of nanotechnologies for drug delivery to the brain. Pharmaceutics 14(2):224. https:\/\/doi.org\/10.3390\/pharmaceutics14020224","journal-title":"Pharmaceutics"},{"issue":"3","key":"4506_CR83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/neup.12638","volume":"40","author":"A Arakawa","year":"2020","unstructured":"Arakawa A, Saito Y, Seki T et al (2020) Corticobasal degeneration with deep white matter lesion diagnosed by brain biopsy. Neuropathology 40(3):287\u2013294. https:\/\/doi.org\/10.1111\/neup.12638","journal-title":"Neuropathology"},{"issue":"3","key":"4506_CR84","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.2008.00231.x","volume":"19","author":"T Zeis","year":"2009","unstructured":"Zeis T, Probst A, Steck AJ, Stadelmann C, Br\u00fcck W, Schaeren-Wiemers N (2009) Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 19(3):459\u2013466. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00231.x","journal-title":"Brain Pathol"},{"issue":"1","key":"4506_CR85","first-page":"59","volume":"71","author":"RB Sorrells","year":"1974","unstructured":"Sorrells RB (1974) Synovioanalysis (\u201cliquid biopsy\u201d). J Ark Med Soc 71(1):59\u201362","journal-title":"J Ark Med Soc"},{"issue":"7","key":"4506_CR86","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/14737159.2014.943193","volume":"14","author":"DR Santiago-Dieppa","year":"2014","unstructured":"Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS, Chen CC (2014) Extracellular vesicles as a platform for \u2018liquid biopsy\u2019 in glioblastoma patients. Expert Rev Mol Diagn 14(7):819\u2013825. https:\/\/doi.org\/10.1586\/14737159.2014.943193","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"4506_CR87","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s10072-023-06806-9","volume":"44","author":"V Pieri","year":"2023","unstructured":"Pieri V, Curti DG, Paterra R et al (2023) CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder. Neurol Sci 44(9):3271\u20133277. https:\/\/doi.org\/10.1007\/s10072-023-06806-9","journal-title":"Neurol Sci"},{"key":"4506_CR88","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnagi.2018.00343","volume":"10","author":"FM Elahi","year":"2018","unstructured":"Elahi FM, Casaletto KB, Altendahl M et al (2018) \u201cLiquid biopsy\u201d of white matter hyperintensity in functionally normal elders. Front Aging Neurosci 10:343. https:\/\/doi.org\/10.3389\/fnagi.2018.00343","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"4506_CR89","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 149(2):351\u2013356. https:\/\/doi.org\/10.2214\/ajr.149.2.351","journal-title":"AJR Am J Roentgenol."},{"issue":"7","key":"4506_CR90","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s00415-017-8550-8","volume":"264","author":"Y Li","year":"2017","unstructured":"Li Y, Li M, Zhang X et al (2017) Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden. J Neurol 264(7):1474\u20131481. https:\/\/doi.org\/10.1007\/s00415-017-8550-8","journal-title":"J Neurol"},{"issue":"2","key":"4506_CR91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12264-022-00969-9","volume":"39","author":"M Jin","year":"2023","unstructured":"Jin M, Cai SQ (2023) Mechanisms underlying brain aging under normal and pathological conditions. Neurosci Bull 39(2):303\u2013314. https:\/\/doi.org\/10.1007\/s12264-022-00969-9","journal-title":"Neurosci Bull"},{"issue":"7","key":"4506_CR92","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00018-023-04832-6","volume":"80","author":"F Gaspar-Silva","year":"2023","unstructured":"Gaspar-Silva F, Trigo D, Magalhaes J (2023) Ageing in the brain: mechanisms and rejuvenating strategies. Cell Mol Life Sci 80(7):190. https:\/\/doi.org\/10.1007\/s00018-023-04832-6","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"4506_CR93","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254\u20131266. https:\/\/doi.org\/10.7150\/ijbs.4679","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4506_CR94","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"E Lyra","year":"2021","unstructured":"Lyra E, Silva NM, Gon\u00e7alves RA, Pascoal TA et al (2021) Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl Psychiatry 11(1):251. https:\/\/doi.org\/10.1038\/s41398-021-01349-z","journal-title":"Transl Psychiatry"},{"issue":"9","key":"4506_CR95","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.3390\/nu13093220","volume":"13","author":"K Higuchi","year":"2021","unstructured":"Higuchi K, Sivaprakasam S, Sennoune SR et al (2021) A proton-coupled transport system for \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) in blood-brain barrier endothelial cell line hCMEC\/D3. Nutrients 13(9):3220. https:\/\/doi.org\/10.3390\/nu13093220","journal-title":"Nutrients"},{"key":"4506_CR96","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2016.01.004","volume":"40","author":"DG Kougias","year":"2016","unstructured":"Kougias DG, Nolan SO, Koss WA et al (2016) Beta-hydroxy-beta-methylbutyrate ameliorates aging effects in the dendritic tree of pyramidal neurons in the medial prefrontal cortex of both male and female rats. Neurobiol Aging 40:78\u201385. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.004","journal-title":"Neurobiol Aging"},{"issue":"8","key":"4506_CR97","doi-asserted-by":"publisher","first-page":"e0135614","DOI":"10.1371\/journal.pone.0135614","volume":"10","author":"R Salto","year":"2015","unstructured":"Salto R, V\u00edlchez JD, Gir\u00f3n MD et al (2015) \u03b2-Hydroxy-\u03b2-methylbutyrate (HMB) promotes neurite outgrowth in Neuro2a cells. PLoS ONE 10(8):e0135614. https:\/\/doi.org\/10.1371\/journal.pone.0135614","journal-title":"PLoS ONE"},{"key":"4506_CR98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.physbeh.2016.12.025","volume":"170","author":"DG Kougias","year":"2017","unstructured":"Kougias DG, Hankosky ER, Gulley JM, Juraska JM (2017) Beta-hydroxy-beta-methylbutyrate (HMB) ameliorates age-related deficits in water maze performance, especially in male rats. Physiol Behav 170:93\u201399. https:\/\/doi.org\/10.1016\/j.physbeh.2016.12.025","journal-title":"Physiol Behav"},{"issue":"1","key":"4506_CR99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1750-3639.1993.tb00729.x","volume":"3","author":"G Thiel","year":"1993","unstructured":"Thiel G (1993) Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles. Brain Pathol 3(1):87\u201395. https:\/\/doi.org\/10.1111\/j.1750-3639.1993.tb00729.x","journal-title":"Brain Pathol"},{"issue":"1","key":"4506_CR100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13041-019-0520-x","volume":"12","author":"KS Yoo","year":"2019","unstructured":"Yoo KS, Lee K, Oh JY et al (2019) Postsynaptic density protein 95 (PSD-95) is transported by KIF5 to dendritic regions. Mol Brain 12(1):97. https:\/\/doi.org\/10.1186\/s13041-019-0520-x","journal-title":"Mol Brain"},{"issue":"1\u20132","key":"4506_CR101","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0006-8993(00)02758-x","volume":"879","author":"T Kageyama","year":"2000","unstructured":"Kageyama T, Nakamura M, Matsuo A et al (2000) The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res 879(1\u20132):115\u2013121. https:\/\/doi.org\/10.1016\/s0006-8993(00)02758-x","journal-title":"Brain Res"},{"issue":"1","key":"4506_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/nu10010023","volume":"10","author":"N Hodson","year":"2017","unstructured":"Hodson N, Brown T, Joanisse S et al (2017) Characterisation of L-type amino acid transporter 1 (LAT1) expression in human skeletal muscle by immunofluorescent microscopy. Nutrients 10(1):23. https:\/\/doi.org\/10.3390\/nu10010023","journal-title":"Nutrients"},{"key":"4506_CR103","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1038\/s41598-024-55252-w","volume":"14","author":"S Chen","year":"2024","unstructured":"Chen S, Jin C, Ohgaki R et al (2024) Structure\u2013activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1). Sci Rep 14:4651. https:\/\/doi.org\/10.1038\/s41598-024-55252-w","journal-title":"Sci Rep"},{"issue":"4","key":"4506_CR104","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/polym14040712","volume":"14","author":"S Habib","year":"2022","unstructured":"Habib S, Singh M (2022) Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: a review. Polymers (Basel) 14(4):712. https:\/\/doi.org\/10.3390\/polym14040712","journal-title":"Polymers (Basel)"},{"issue":"16","key":"4506_CR105","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.3390\/ijms23169361","volume":"23","author":"K Jagaran","year":"2022","unstructured":"Jagaran K, Singh M (2022) Lipid nanoparticles: promising treatment approach for Parkinson\u2019s disease. Int J Mol Sci 23(16):9361. https:\/\/doi.org\/10.3390\/ijms23169361","journal-title":"Int J Mol Sci"},{"issue":"42","key":"4506_CR106","doi-asserted-by":"publisher","first-page":"8314","DOI":"10.1039\/c7tb02247f","volume":"5","author":"LV Nair","year":"2017","unstructured":"Nair LV, Nair RV, Shenoy SJ, Thekkuveettil A, Jayasree RS (2017) Blood brain barrier permeable gold nanocluster for targeted brain imaging and therapy: an in vitro and in vivo study. J Mater Chem B 5(42):8314\u20138321. https:\/\/doi.org\/10.1039\/c7tb02247f","journal-title":"J Mater Chem B"},{"issue":"1","key":"4506_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2018.08.011","volume":"15","author":"DA Gonzalez-Carter","year":"2019","unstructured":"Gonzalez-Carter DA, Ong ZY, McGilvery CM, Dunlop IE, Dexter DT, Porter AE (2019) L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. Nanomedicine 15(1):1\u201311. https:\/\/doi.org\/10.1016\/j.nano.2018.08.011","journal-title":"Nanomedicine"},{"issue":"45","key":"4506_CR108","doi-asserted-by":"publisher","first-page":"39259","DOI":"10.1021\/acsami.7b14851","volume":"9","author":"ZY Ong","year":"2017","unstructured":"Ong ZY, Chen S, Nabavi E et al (2017) Multibranched gold nanoparticles with intrinsic LAT-1 targeting capabilities for selective photothermal therapy of breast cancer. ACS Appl Mater Interfaces 9(45):39259\u201339270. https:\/\/doi.org\/10.1021\/acsami.7b14851","journal-title":"ACS Appl Mater Interfaces"},{"issue":"17","key":"4506_CR109","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.bmcl.2018.07.030","volume":"28","author":"NA Thiele","year":"2018","unstructured":"Thiele NA, K\u00e4rkk\u00e4inen J, Sloan KB, Rautio J, Huttunen KM (2018) Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug. Bioorg Med Chem Lett 28(17):2856\u20132860. https:\/\/doi.org\/10.1016\/j.bmcl.2018.07.030","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"4506_CR110","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","volume":"64","author":"M Alas","year":"2021","unstructured":"Alas M, Saghaeidehkordi A, Kaur K (2021) Peptide-drug conjugates with different linkers for cancer therapy. J Med Chem 64(1):216\u2013232. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01530","journal-title":"J Med Chem"},{"key":"4506_CR111","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.toxrep.2023.12.004","volume":"12","author":"M Nasrabadi","year":"2024","unstructured":"Nasrabadi M, Nazarian M, Darroudi M et al (2024) Carbamate compounds induced toxic effects by affecting Nrf2 signaling pathways. Toxicol Rep 12:148\u2013157. https:\/\/doi.org\/10.1016\/j.toxrep.2023.12.004","journal-title":"Toxicol Rep"},{"issue":"9","key":"4506_CR112","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s00204-020-02826-y","volume":"94","author":"S Gutbier","year":"2020","unstructured":"Gutbier S, Kyriakou S, Schildknecht S et al (2020) Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants. Arch Toxicol 94(9):3105\u20133123. https:\/\/doi.org\/10.1007\/s00204-020-02826-y","journal-title":"Arch Toxicol"},{"issue":"1","key":"4506_CR113","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10571-024-01459-4","volume":"44","author":"W Zeng","year":"2024","unstructured":"Zeng W, Cai J, Zhang L, Peng Q (2024) Iron deposition in Parkinson\u2019s disease: a mini-review. Cell Mol Neurobiol 44(1):26. https:\/\/doi.org\/10.1007\/s10571-024-01459-4","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"4506_CR114","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s11095-012-0966-3","volume":"30","author":"L Peura","year":"2013","unstructured":"Peura L, Malmioja K, Huttunen K et al (2013) Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine. Pharm Res 30(10):2523\u20132537. https:\/\/doi.org\/10.1007\/s11095-012-0966-3","journal-title":"Pharm Res"},{"issue":"3","key":"4506_CR115","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cbic.201900320","volume":"21","author":"S Gr\u00fcschow","year":"2020","unstructured":"Gr\u00fcschow S, Sadler JC, Sharratt PJ, Goss RJM (2020) Phenylalanine meta-hydroxylase: a single residue mediates mechanistic control of aromatic amino acid hydroxylation. ChemBioChem 21(3):417\u2013422. https:\/\/doi.org\/10.1002\/cbic.201900320","journal-title":"ChemBioChem"},{"issue":"16","key":"4506_CR116","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1097\/00001756-200011090-00021","volume":"11","author":"H Matsuo","year":"2000","unstructured":"Matsuo H, Tsukada S, Nakata T et al (2000) Expression of a system L neutral amino acid transporter at the blood-brain barrier. NeuroReport 11(16):3507\u20133511. https:\/\/doi.org\/10.1097\/00001756-200011090-00021","journal-title":"NeuroReport"},{"issue":"7","key":"4506_CR117","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1248\/bpb.33.1250","volume":"33","author":"S Ohtsuki","year":"2010","unstructured":"Ohtsuki S, Yamaguchi H, Kang YS, Hori S, Terasaki T (2010) Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson\u2019s disease. Biol Pharm Bull 33(7):1250\u20131252. https:\/\/doi.org\/10.1248\/bpb.33.1250","journal-title":"Biol Pharm Bull"},{"issue":"23","key":"4506_CR118","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1016\/j.bpj.2022.11.001","volume":"121","author":"K Hutchinson","year":"2022","unstructured":"Hutchinson K, Silva DB, Bohlke J et al (2022) Describing inhibitor specificity for the amino acid transporter LAT1 from metainference simulations. Biophys J 121(23):4476\u20134491. https:\/\/doi.org\/10.1016\/j.bpj.2022.11.001","journal-title":"Biophys J"},{"key":"4506_CR119","doi-asserted-by":"publisher","first-page":"120300","DOI":"10.1016\/j.ijpharm.2021.120300","volume":"596","author":"AJ Jalkanen","year":"2021","unstructured":"Jalkanen AJ, Ihalainen J, Lehtonen M et al (2021) Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats. Int J Pharm 596:120300. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120300","journal-title":"Int J Pharm"},{"key":"4506_CR120","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fchem.2018.00243","volume":"6","author":"M Scalise","year":"2018","unstructured":"Scalise M, Galluccio M, Console L, Pochini L, Indiveri C (2018) The human SLC7A5 (LAT1): the intriguing histidine\/large neutral amino acid transporter and its relevance to human health. Front Chem 6:243. https:\/\/doi.org\/10.3389\/fchem.2018.00243","journal-title":"Front Chem"},{"issue":"7","key":"4506_CR121","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.sjbs.2021.03.049","volume":"28","author":"I Aganovic-Musinovic","year":"2021","unstructured":"Aganovic-Musinovic I, Burnazovic-Ristic L, Kusturica J et al (2021) Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats. Saudi J Biol Sci 28(7):3816\u20133822. https:\/\/doi.org\/10.1016\/j.sjbs.2021.03.049","journal-title":"Saudi J Biol Sci"},{"key":"4506_CR122","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-015-0016-8","volume":"12","author":"G Wittmann","year":"2015","unstructured":"Wittmann G, Moh\u00e1csik P, Balkhi MY, Gereben B, Lechan RM (2015) Endotoxin-induced inflammation down-regulates L-type amino acid transporter 1 (LAT1) expression at the blood-brain barrier of male rats and mice. Fluids Barriers CNS 12:21. https:\/\/doi.org\/10.1186\/s12987-015-0016-8","journal-title":"Fluids Barriers CNS"},{"issue":"1\u20132","key":"4506_CR123","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijpharm.2010.08.019","volume":"399","author":"M Gynther","year":"2010","unstructured":"Gynther M, Jalkanen A, Lehtonen M et al (2010) Brain uptake of ketoprofen-lysine prodrug in rats. Int J Pharm 399(1\u20132):121\u2013128. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.08.019","journal-title":"Int J Pharm"},{"issue":"7","key":"4506_CR124","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/acs.molpharmaceut.9b00502","volume":"16","author":"E Puris","year":"2019","unstructured":"Puris E, Gynther M, de Lange ECM et al (2019) Mechanistic study on the use of the l-type amino acid transporter 1 for brain intracellular delivery of ketoprofen via prodrug: a novel approach supporting the development of prodrugs for intracellular targets. Mol Pharm 16(7):3261\u20133274. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00502","journal-title":"Mol Pharm"},{"issue":"4","key":"4506_CR125","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/pharmaceutics12040344","volume":"12","author":"A Montaser","year":"2020","unstructured":"Montaser A, Lehtonen M, Gynther M, Huttunen KM (2020) L-type amino acid transporter 1-utilizing prodrugs of ketoprofen can efficiently reduce brain prostaglandin levels. Pharmaceutics 12(4):344. https:\/\/doi.org\/10.3390\/pharmaceutics12040344","journal-title":"Pharmaceutics"},{"issue":"5","key":"4506_CR126","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/mp900084v","volume":"6","author":"D Gupta","year":"2009","unstructured":"Gupta D, Gupta SV, Lee KD, Amidon GL (2009) Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers. Mol Pharm 6(5):1604\u20131611. https:\/\/doi.org\/10.1021\/mp900084v","journal-title":"Mol Pharm"},{"issue":"24","key":"4506_CR127","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1021\/acschemneuro.0c00564","volume":"11","author":"AB Montaser","year":"2020","unstructured":"Montaser AB, J\u00e4rvinen J, L\u00f6ffler S et al (2020) L-type amino acid transporter 1 enables the efficient brain delivery of small-sized prodrug across the blood-brain barrier and into human and mouse brain parenchymal cells. ACS Chem Neurosci 11(24):4301\u20134315. https:\/\/doi.org\/10.1021\/acschemneuro.0c00564","journal-title":"ACS Chem Neurosci"},{"key":"4506_CR128","doi-asserted-by":"publisher","first-page":"869269","DOI":"10.1155\/2014\/869269","volume":"2014","author":"RK Upadhyay","year":"2014","unstructured":"Upadhyay RK (2014) Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int 2014:869269. https:\/\/doi.org\/10.1155\/2014\/869269","journal-title":"Biomed Res Int"},{"key":"4506_CR129","doi-asserted-by":"publisher","first-page":"120565","DOI":"10.1016\/j.ijpharm.2021.120565","volume":"601","author":"J Tampio","year":"2021","unstructured":"Tampio J, L\u00f6ffler S, Guillon M, Hugele A, Huttunen J, Huttunen KM (2021) Improved l-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production. Int J Pharm 601:120565. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120565","journal-title":"Int J Pharm"},{"issue":"11","key":"4506_CR130","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1007\/s12035-020-02045-7","volume":"57","author":"J Tampio","year":"2020","unstructured":"Tampio J, Huttunen J, Montaser A, Huttunen KM (2020) Targeting of perforin inhibitor into the brain parenchyma via a prodrug approach can decrease oxidative stress and neuroinflammation and improve cell survival. Mol Neurobiol 57(11):4563\u20134577. https:\/\/doi.org\/10.1007\/s12035-020-02045-7","journal-title":"Mol Neurobiol"},{"issue":"4","key":"4506_CR131","doi-asserted-by":"publisher","first-page":"e200117","DOI":"10.1212\/NXI.0000000000200117","volume":"10","author":"C Gonzalez-Fierro","year":"2023","unstructured":"Gonzalez-Fierro C, Fonte C, Dufourd E et al (2023) Effects of a small-molecule perforin inhibitor in a mouse model of CD8 T cell-mediated neuroinflammation. Neurol Neuroimmunol Neuroinflamm 10(4):e200117. https:\/\/doi.org\/10.1212\/NXI.0000000000200117","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"21","key":"4506_CR132","doi-asserted-by":"publisher","first-page":"14305","DOI":"10.1021\/acs.jmedchem.2c01338","volume":"65","author":"JA Spicer","year":"2022","unstructured":"Spicer JA, Huttunen KM, Jose J et al (2022) Small molecule inhibitors of lymphocyte perforin as focused immunosuppressants for infection and autoimmunity. J Med Chem 65(21):14305\u201314325. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01338","journal-title":"J Med Chem"},{"issue":"1","key":"4506_CR133","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1023\/a:1005638627604","volume":"23","author":"RA Moats","year":"2000","unstructured":"Moats RA, Koch R, Moseley K et al (2000) Brain phenylalanine concentration in the management of adults with phenylketonuria. J Inherit Metab Dis 23(1):7\u201314. https:\/\/doi.org\/10.1023\/a:1005638627604","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"4506_CR134","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1542\/peds.106.5.1093","volume":"106","author":"R Koch","year":"2000","unstructured":"Koch R, Moats R, Guttler F, Guldberg P, Nelson M Jr (2000) Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 106(5):1093\u20131096. https:\/\/doi.org\/10.1542\/peds.106.5.1093","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"4506_CR135","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.ymgme.2005.07.031","volume":"86","author":"LB M\u00f8ller","year":"2005","unstructured":"M\u00f8ller LB, Paulsen M, Koch R, Moats R, Guldberg P, G\u00fcttler F (2005) Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc\/LAT1 complex. Mol Genet Metab 86(Suppl 1):S119\u2013S123. https:\/\/doi.org\/10.1016\/j.ymgme.2005.07.031","journal-title":"Mol Genet Metab"},{"issue":"4","key":"4506_CR136","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ymgme.2004.07.008","volume":"83","author":"RJ Boado","year":"2004","unstructured":"Boado RJ, Li JY, Wise P, Pardridge WM (2004) Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport. Mol Genet Metab 83(4):306\u2013311. https:\/\/doi.org\/10.1016\/j.ymgme.2004.07.008","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4506_CR137","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s10545-006-0285-0","volume":"29","author":"M Bik-Multanowski","year":"2006","unstructured":"Bik-Multanowski M, Pietrzyk JJ (2006) LAT1 gene variants\u2013potential factors influencing the clinical course of phenylketonuria. J Inherit Metab Dis 29(5):684. https:\/\/doi.org\/10.1007\/s10545-006-0285-0","journal-title":"J Inherit Metab Dis"},{"key":"4506_CR138","doi-asserted-by":"publisher","first-page":"100751","DOI":"10.1016\/j.ymgmr.2021.100751","volume":"27","author":"M Bik-Multanowski","year":"2021","unstructured":"Bik-Multanowski M, Bik-Multanowska K, Betka I, Madetko-Talowska A (2021) The rs113883650 variant of SLC7A5 (LAT1) gene may alter brain phenylalanine content in PKU. Mol Genet Metab Rep 27:100751. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100751","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"4506_CR139","doi-asserted-by":"publisher","first-page":"e0264084","DOI":"10.1371\/journal.pone.0264084","volume":"17","author":"M Bik-Multanowski","year":"2022","unstructured":"Bik-Multanowski M, Didycz B, Bik-Multanowska K (2022) Management precautions for risk of obesity are necessary among infants with PKU carrying the rs113883650 variant of the LAT1 gene: a cross-sectional study. PLoS ONE 17(2):e0264084. https:\/\/doi.org\/10.1371\/journal.pone.0264084","journal-title":"PLoS ONE"},{"issue":"2","key":"4506_CR140","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2022.03.012","volume":"136","author":"SF Dobrowolski","year":"2022","unstructured":"Dobrowolski SF, Phua YL, Vockley J, Goetzman E, Blair HC (2022) Phenylketonuria oxidative stress and energy dysregulation: emerging pathophysiological elements provide interventional opportunity. Mol Genet Metab 136(2):111\u2013117. https:\/\/doi.org\/10.1016\/j.ymgme.2022.03.012","journal-title":"Mol Genet Metab"},{"issue":"3","key":"4506_CR141","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10545-012-9524-8","volume":"36","author":"KR Vogel","year":"2013","unstructured":"Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM (2013) Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice. J Inherit Metab Dis 36(3):513\u2013523. https:\/\/doi.org\/10.1007\/s10545-012-9524-8","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4506_CR142","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/a-1290-0119","volume":"71","author":"M Dhanawat","year":"2021","unstructured":"Dhanawat M, Gupta S, Mehta DK, Das R (2021) Design, synthesis and enhanced BBB penetration studies of L-serine-tethered nipecotic acid-prodrug. Drug Res (Stuttg) 71(2):94\u2013103. https:\/\/doi.org\/10.1055\/a-1290-0119","journal-title":"Drug Res (Stuttg)"},{"issue":"20","key":"4506_CR143","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.3390\/molecules27206984","volume":"27","author":"G Papagiouvannis","year":"2022","unstructured":"Papagiouvannis G, Theodosis-Nobelos P, Rekka EA (2022) Nipecotic acid derivatives as potent agents against neurodegeneration: a preliminary study. Molecules 27(20):6984. https:\/\/doi.org\/10.3390\/molecules27206984","journal-title":"Molecules"},{"issue":"11","key":"4506_CR144","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.bcp.2013.03.022","volume":"85","author":"D Dickens","year":"2013","unstructured":"Dickens D, Webb SD, Antonyuk S et al (2013) Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharmacol 85(11):1672\u20131683. https:\/\/doi.org\/10.1016\/j.bcp.2013.03.022","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"4506_CR145","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11095-018-2532-0","volume":"35","author":"Y Takahashi","year":"2018","unstructured":"Takahashi Y, Nishimura T, Higuchi K et al (2018) Transport of pregabalin via L-type amino acid transporter 1 (SLC7A5) in human brain capillary endothelial cell line. Pharm Res 35(12):246. https:\/\/doi.org\/10.1007\/s11095-018-2532-0","journal-title":"Pharm Res"},{"issue":"4","key":"4506_CR146","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1021\/mp900178j","volume":"7","author":"SM Carl","year":"2010","unstructured":"Carl SM, Lindley DJ, Das D et al (2010) ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood\u2013brain barrier cell line, hCMEC\/D3. Mol Pharm 7(4):1057\u20131068. https:\/\/doi.org\/10.1021\/mp900178j","journal-title":"Mol Pharm"},{"issue":"5","key":"4506_CR147","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/mp2001878","volume":"8","author":"L Peura","year":"2011","unstructured":"Peura L, Malmioja K, Laine K et al (2011) Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery. Mol Pharm 8(5):1857\u20131866. https:\/\/doi.org\/10.1021\/mp2001878","journal-title":"Mol Pharm"},{"key":"4506_CR148","doi-asserted-by":"publisher","first-page":"106637","DOI":"10.1016\/j.ejps.2023.106637","volume":"192","author":"J J\u00e4rvinen","year":"2024","unstructured":"J\u00e4rvinen J, Montaser AB, Adla SK et al (2024) Altering distribution profile of palbociclib by its prodrugs. Eur J Pharm Sci 192:106637. https:\/\/doi.org\/10.1016\/j.ejps.2023.106637","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"4506_CR149","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s11064-016-1996-8","volume":"41","author":"M Gynther","year":"2016","unstructured":"Gynther M, Peura L, Vernerov\u00e1 M et al (2016) Amino acid promoieties alter valproic acid pharmacokinetics and enable extended brain exposure. Neurochem Res 41(10):2797\u20132809. https:\/\/doi.org\/10.1007\/s11064-016-1996-8","journal-title":"Neurochem Res"},{"issue":"6","key":"4506_CR150","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC T\u0103rlungeanu","year":"2016","unstructured":"T\u0103rlungeanu DC, Deliu E, Dotter CP et al (2016) Impaired Amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167(6):1481-1494.e18. https:\/\/doi.org\/10.1016\/j.cell.2016.11.013","journal-title":"Cell"},{"issue":"1","key":"4506_CR151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2040-2392-4-16","volume":"4","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Chen CF, Pittman AR et al (2013) Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism 4(1):16. https:\/\/doi.org\/10.1186\/2040-2392-4-16","journal-title":"Mol Autism"},{"key":"4506_CR152","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13229-017-0183-3","volume":"9","author":"A Anwar","year":"2018","unstructured":"Anwar A, Abruzzo PM, Pasha S et al (2018) Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. Mol Autism 9:3. https:\/\/doi.org\/10.1186\/s13229-017-0183-3","journal-title":"Mol Autism"},{"issue":"1","key":"4506_CR153","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1002\/mgg3.1036","volume":"8","author":"L Cascio","year":"2020","unstructured":"Cascio L, Chen CF, Pauly R et al (2020) Abnormalities in the genes that encode large amino acid transporters increase the risk of autism spectrum disorder. Mol Genet Genomic Med 8(1):e1036. https:\/\/doi.org\/10.1002\/mgg3.1036","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"4506_CR154","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jimd.12689","volume":"47","author":"S Illescas","year":"2024","unstructured":"Illescas S, Diaz-Osorio Y, Serradell A et al (2024) Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmission. J Inherit Metab Dis 47(3):551\u2013569. https:\/\/doi.org\/10.1002\/jimd.12689","journal-title":"J Inherit Metab Dis"},{"key":"4506_CR155","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/7854_2016_12","volume":"31","author":"J Savitz","year":"2017","unstructured":"Savitz J (2017) Role of kynurenine metabolism pathway activation in major depressive disorders. Curr Top Behav Neurosci 31:249\u2013267. https:\/\/doi.org\/10.1007\/7854_2016_12","journal-title":"Curr Top Behav Neurosci"},{"issue":"10","key":"4506_CR156","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41380-018-0076-7","volume":"24","author":"AK Walker","year":"2019","unstructured":"Walker AK, Wing EE, Banks WA, Dantzer R (2019) Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice. Mol Psychiatry 24(10):1523\u20131532. https:\/\/doi.org\/10.1038\/s41380-018-0076-7","journal-title":"Mol Psychiatry"},{"issue":"6","key":"4506_CR157","doi-asserted-by":"publisher","first-page":"e006728","DOI":"10.1136\/jitc-2023-006728","volume":"11","author":"M Solvay","year":"2023","unstructured":"Solvay M, Holfelder P, Klaessens S et al (2023) Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. J Immunother Cancer 11(6):e006728. https:\/\/doi.org\/10.1136\/jitc-2023-006728","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4506_CR158","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/acs.molpharmaceut.0c00727","volume":"18","author":"W Patel","year":"2021","unstructured":"Patel W, Rimmer L, Smith M et al (2021) Probenecid increases the concentration of 7-chlorokynurenic acid derived from the prodrug 4-chlorokynurenine within the prefrontal cortex. Mol Pharm 18(1):113\u2013123. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00727","journal-title":"Mol Pharm"},{"issue":"1","key":"4506_CR159","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/jpet.115.225664","volume":"355","author":"P Zanos","year":"2015","unstructured":"Zanos P, Piantadosi SC, Wu HQ et al (2015) The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/glycineB-site inhibition. J Pharmacol Exp Ther 355(1):76\u201385. https:\/\/doi.org\/10.1124\/jpet.115.225664","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"4506_CR160","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/acs.molpharmaceut.3c00700","volume":"21","author":"W Patel","year":"2024","unstructured":"Patel W, Shankar RG, Smith MA et al (2024) Role of transporters and enzymes in metabolism and distribution of 4-chlorokynurenine (AV-101). Mol Pharm 21(2):550\u2013563. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00700","journal-title":"Mol Pharm"},{"key":"4506_CR161","doi-asserted-by":"publisher","first-page":"123356","DOI":"10.1016\/j.envpol.2024.123356","volume":"346","author":"Z Yu","year":"2024","unstructured":"Yu Z, Lin Y, Wu L et al (2024) Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the \u201cliver-brain\u201d axis. Environ Pollut 346:123356. https:\/\/doi.org\/10.1016\/j.envpol.2024.123356","journal-title":"Environ Pollut"},{"key":"4506_CR162","doi-asserted-by":"publisher","first-page":"113734","DOI":"10.1016\/j.ecoenv.2022.113734","volume":"241","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhou L, Wu XC et al (2022) Association of serum bisphenol AF concentration with depressive symptoms in adolescents: a nested case-control study in China. Ecotoxicol Environ Saf 241:113734. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113734","journal-title":"Ecotoxicol Environ Saf"},{"issue":"31","key":"4506_CR163","doi-asserted-by":"publisher","first-page":"28191","DOI":"10.1074\/jbc.M204011200","volume":"277","author":"JM Falc\u00f3n-P\u00e9rez","year":"2002","unstructured":"Falc\u00f3n-P\u00e9rez JM, Starcevic M, Gautam R, Dell\u2019Angelica EC (2002) BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet-dense granules. J Biol Chem 277(31):28191\u201328199. https:\/\/doi.org\/10.1074\/jbc.M204011200","journal-title":"J Biol Chem"},{"issue":"9","key":"4506_CR164","doi-asserted-by":"publisher","first-page":"113025","DOI":"10.1016\/j.celrep.2023.113025","volume":"42","author":"H Li","year":"2023","unstructured":"Li H, Aboudhiaf S, Parrot S et al (2023) Pallidin function in Drosophila surface glia regulates sleep and is dependent on amino acid availability. Cell Rep 42(9):113025. https:\/\/doi.org\/10.1016\/j.celrep.2023.113025","journal-title":"Cell Rep"},{"key":"4506_CR165","doi-asserted-by":"publisher","first-page":"114265","DOI":"10.1016\/j.psychres.2021.114265","volume":"307","author":"M Lai","year":"2022","unstructured":"Lai M, Hegde R, Kelly S et al (2022) Investigating sleep spindle density and schizophrenia: a meta-analysis. Psychiatry Res 307:114265. https:\/\/doi.org\/10.1016\/j.psychres.2021.114265","journal-title":"Psychiatry Res"},{"issue":"5","key":"4506_CR166","doi-asserted-by":"publisher","first-page":"e0233629","DOI":"10.1371\/journal.pone.0233629","volume":"15","author":"JJ Lu","year":"2020","unstructured":"Lu JJ, Li P, Yang Y et al (2020) Prognostic value of LAT-1 status in solid cancer: a systematic review and meta-analysis. PLoS ONE 15(5):e0233629. https:\/\/doi.org\/10.1371\/journal.pone.0233629","journal-title":"PLoS ONE"},{"issue":"10","key":"4506_CR167","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.3390\/ijms20102428","volume":"20","author":"P H\u00e4fliger","year":"2019","unstructured":"H\u00e4fliger P, Charles RP (2019) The L-type amino acid transporter LAT1-an emerging target in cancer. Int J Mol Sci 20(10):2428. https:\/\/doi.org\/10.3390\/ijms20102428","journal-title":"Int J Mol Sci"},{"key":"4506_CR168","doi-asserted-by":"publisher","first-page":"115103","DOI":"10.1016\/j.bcp.2022.115103","volume":"201","author":"N Cappoli","year":"2022","unstructured":"Cappoli N, Jenkinson MD, Dello Russo C, Dickens D (2022) LAT1, a novel pharmacological target for the treatment of glioblastoma. Biochem Pharmacol 201:115103. https:\/\/doi.org\/10.1016\/j.bcp.2022.115103","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"4506_CR169","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.3390\/ijms24119393","volume":"24","author":"F Anagnostakis","year":"2023","unstructured":"Anagnostakis F, Kokkorakis M, Markouli M, Piperi C (2023) Impact of solute carrier transporters in glioma pathology: a comprehensive review. Int J Mol Sci 24(11):9393. https:\/\/doi.org\/10.3390\/ijms24119393","journal-title":"Int J Mol Sci"},{"key":"4506_CR170","doi-asserted-by":"publisher","first-page":"106661","DOI":"10.1016\/j.ejps.2023.106661","volume":"195","author":"K Bahrami","year":"2024","unstructured":"Bahrami K, K\u00e4rkk\u00e4inen J, Bibi S et al (2024) Specific transport of temozolomide does not override DNA repair-mediated chemoresistance. Eur J Pharm Sci 195:106661. https:\/\/doi.org\/10.1016\/j.ejps.2023.106661","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"4506_CR171","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/cpt.1710","volume":"107","author":"X Bao","year":"2020","unstructured":"Bao X, Wu J, Xie Y et al (2020) Protein expression and functional relevance of efflux and uptake drug transporters at the blood-brain barrier of human brain and glioblastoma. Clin Pharmacol Ther 107(5):1116\u20131127. https:\/\/doi.org\/10.1002\/cpt.1710","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"4506_CR172","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1021\/acs.molpharmaceut.7b00569","volume":"14","author":"S Bhunia","year":"2017","unstructured":"Bhunia S, Vangala V, Bhattacharya D et al (2017) Large amino acid transporter 1 selective liposomes of l-DOPA functionalized amphiphile for combating glioblastoma. Mol Pharm 14(11):3834\u20133847. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00569","journal-title":"Mol Pharm"},{"issue":"1","key":"4506_CR173","first-page":"147","volume":"32","author":"ZY Wei","year":"2018","unstructured":"Wei ZY, Feng MM, Yang B, Yan ZY, Wang BQ, Bu XY (2018) Methylmercury-l-cysteine targeting L-type amino acid transporter conjugate cytotoxicity on C6 glioma cells. J Biol Regul Homeost Agents 32(1):147\u2013151","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"4506_CR174","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1471-4159.2008.05683.x","volume":"107","author":"Z Yin","year":"2008","unstructured":"Yin Z, Jiang H, Syversen T, Rocha JB, Farina M, Aschner M (2008) The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J Neurochem 107(4):1083\u20131090. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05683.x","journal-title":"J Neurochem"},{"key":"4506_CR175","doi-asserted-by":"publisher","first-page":"119585","DOI":"10.1016\/j.ijpharm.2020.119585","volume":"586","author":"A Montaser","year":"2020","unstructured":"Montaser A, Markowicz-Piasecka M, Sikora J, Jalkanen A, Huttunen KM (2020) L-type amino acid transporter 1 (LAT1)-utilizing efflux transporter inhibitors can improve the brain uptake and apoptosis-inducing effects of vinblastine in cancer cells. Int J Pharm 586:119585. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119585","journal-title":"Int J Pharm"},{"issue":"13","key":"4506_CR176","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.15252\/embj.201488166","volume":"34","author":"SG Dann","year":"2015","unstructured":"Dann SG, Ryskin M, Barsotti AM et al (2015) Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2. EMBO J. 34(13):1773\u20131785. https:\/\/doi.org\/10.15252\/embj.201488166","journal-title":"EMBO J."},{"issue":"3\u20134","key":"4506_CR177","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11011-007-9064-3","volume":"22","author":"TW Stone","year":"2007","unstructured":"Stone TW, Forrest CM, Mackay GM, Stoy N, Darlington LG (2007) Tryptophan, adenosine, neurodegeneration and neuroprotection. Metab Brain Dis 22(3\u20134):337\u2013352. https:\/\/doi.org\/10.1007\/s11011-007-9064-3","journal-title":"Metab Brain Dis"},{"issue":"2","key":"4506_CR178","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12035-020-02143-6","volume":"58","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Gautam S, Hyeon SJ, Ryu H, Kang YS (2021) L-Citrulline level and transporter activity are altered in experimental models of amyotrophic lateral sclerosis. Mol Neurobiol 58(2):647\u2013657. https:\/\/doi.org\/10.1007\/s12035-020-02143-6","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4506_CR179","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/pharmaceutics14102167","volume":"14","author":"S Latif","year":"2022","unstructured":"Latif S, Kang YS (2022) Blood-brain barrier solute carrier transporters and motor neuron disease. Pharmaceutics 14(10):2167. https:\/\/doi.org\/10.3390\/pharmaceutics14102167","journal-title":"Pharmaceutics"},{"issue":"3","key":"4506_CR180","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/bcpt.13534","volume":"128","author":"A Shaheen","year":"2021","unstructured":"Shaheen A, Alam SM, Azam F et al (2021) Influence of single nucleotide polymorphism of LAT1 on therapeutic response to gabapentinoids in Pakistani patients with neuropathic pain. Basic Clin Pharmacol Toxicol 128(3):503\u2013510. https:\/\/doi.org\/10.1111\/bcpt.13534","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"4506_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-021-00297-6","volume":"19","author":"B Ozg\u00fcr","year":"2022","unstructured":"Ozg\u00fcr B, Helms HCC, Tornabene E, Brodin B (2022) Hypoxia increases expression of selected blood-brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers. Fluids Barriers CNS 19(1):1. https:\/\/doi.org\/10.1186\/s12987-021-00297-6","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"4506_CR182","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.xphs.2022.12.028","volume":"112","author":"T Akashi","year":"2023","unstructured":"Akashi T, Noguchi S, Takahashi Y, Nishimura T, Tomi M (2023) L-type amino acid transporter 1 (SLC7A5)-mediated transport of pregabalin at the rat blood-spinal cord barrier and its sensitivity to plasma branched-chain amino acids. J Pharm Sci 112(4):1137\u20131144. https:\/\/doi.org\/10.1016\/j.xphs.2022.12.028","journal-title":"J Pharm Sci"},{"issue":"4","key":"4506_CR183","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00424-021-02653-9","volume":"474","author":"AE Goins","year":"2022","unstructured":"Goins AE, Gomez K, Ran D, Afaghpour-Becklund M, Khanna R, Alles SRA (2022) Neuronal allodynic mechanisms of Slc7a5 (LAT1) in the spared nerve injury rodent model of neuropathic pain. Pflugers Arch 474(4):397\u2013403. https:\/\/doi.org\/10.1007\/s00424-021-02653-9","journal-title":"Pflugers Arch"},{"key":"4506_CR184","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.colsurfb.2015.04.049","volume":"131","author":"A Vyas","year":"2015","unstructured":"Vyas A, Jain A, Hurkat P, Jain A, Jain SK (2015) Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier. Colloids Surf B Biointerfaces 131:155\u2013161. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.04.049","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4506_CR185","doi-asserted-by":"publisher","first-page":"39738","DOI":"10.1038\/srep39738","volume":"6","author":"L Bertrand","year":"2016","unstructured":"Bertrand L, Dygert L, Toborek M (2016) Antiretroviral treatment with efavirenz disrupts the blood-brain barrier integrity and increases stroke severity. Sci Rep 6:39738. https:\/\/doi.org\/10.1038\/srep39738","journal-title":"Sci Rep"},{"issue":"10","key":"4506_CR186","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biomedicines9101320","volume":"9","author":"X Zheng","year":"2021","unstructured":"Zheng X, Yang H, Qin L et al (2021) Bile duct ligation upregulates expression and function of L-amino acid transporter 1 at blood-brain barrier of rats via activation of aryl hydrocarbon receptor by bilirubin. Biomedicines 9(10):1320. https:\/\/doi.org\/10.3390\/biomedicines9101320","journal-title":"Biomedicines"},{"issue":"12","key":"4506_CR187","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1021\/acschemneuro.0c00135","volume":"11","author":"R Krasikova","year":"2020","unstructured":"Krasikova R, Kondrashov M, Avagliano C et al (2020) Synthesis and preclinical evaluation of 6-[18F]fluorine-\u03b1-methyl-l-tryptophan, a novel PET tracer for measuring tryptophan uptake. ACS Chem Neurosci 11(12):1756\u20131761. https:\/\/doi.org\/10.1021\/acschemneuro.0c00135","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"4506_CR188","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/cells9051130","volume":"9","author":"JR Choi","year":"2020","unstructured":"Choi JR, Yong KW, Choi JY, Cowie AC (2020) Single-cell RNA sequencing and its combination with protein and DNA analyses. Cells 9(5):1130. https:\/\/doi.org\/10.3390\/cells9051130","journal-title":"Cells"},{"issue":"1","key":"4506_CR189","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12987-023-00466-9","volume":"20","author":"S Ito","year":"2023","unstructured":"Ito S, Yagi R, Ogata S et al (2023) Proteomic alterations in the brain and blood-brain barrier during brain A\u03b2 accumulation in an APP knock-in mouse model of Alzheimer\u2019s disease. Fluids Barriers CNS 20(1):66. https:\/\/doi.org\/10.1186\/s12987-023-00466-9","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"4506_CR190","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41563-023-01559-4","volume":"22","author":"J Tian","year":"2023","unstructured":"Tian J, Xie SH, Borucu U, Lei S, Zhang Y, Manners I (2023) High-resolution cryo-electron microscopy structure of block copolymer nanofibres with a crystalline core. Nat Mater 22(6):786\u2013792. https:\/\/doi.org\/10.1038\/s41563-023-01559-4","journal-title":"Nat Mater"},{"key":"4506_CR191","doi-asserted-by":"publisher","first-page":"114816","DOI":"10.1016\/j.addr.2023.114816","volume":"196","author":"A P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez A, Torres-Su\u00e1rez AI, Mart\u00edn-Sabroso C, Aparicio-Blanco J (2023) An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. Adv Drug Deliv Rev 196:114816. https:\/\/doi.org\/10.1016\/j.addr.2023.114816","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4506_CR192","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13534-022-00258-4","volume":"13","author":"S Cho","year":"2023","unstructured":"Cho S, Lee S, Ahn SI (2023) Design and engineering of organ-on-a-chip. Biomed Eng Lett 13(2):97\u2013109. https:\/\/doi.org\/10.1007\/s13534-022-00258-4","journal-title":"Biomed Eng Lett"},{"key":"4506_CR193","doi-asserted-by":"publisher","first-page":"103533","DOI":"10.1016\/j.mcn.2020.103533","volume":"107","author":"L Delsing","year":"2020","unstructured":"Delsing L, Herland A, Falk A, Hicks R, Synnergren J, Zetterberg H (2020) Models of the blood-brain barrier using iPSC-derived cells. Mol Cell Neurosci 107:103533. https:\/\/doi.org\/10.1016\/j.mcn.2020.103533","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"4506_CR194","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4252\/wjsc.v15.i6.632","volume":"15","author":"ADH Alves","year":"2023","unstructured":"Alves ADH, Nucci MP, Ennes do Valle NM et al (2023) Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip. World J Stem Cells 15(6):632\u2013653","journal-title":"World J Stem Cells"},{"issue":"5","key":"4506_CR195","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","volume":"37","author":"E Puris","year":"2020","unstructured":"Puris E, Gynther M, Auriola S, Huttunen KM (2020) L-Type amino acid transporter 1 as a target for drug delivery. Pharm Res 37(5):88. https:\/\/doi.org\/10.1007\/s11095-020-02826-8","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"4506_CR196","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijpharm.2018.08.047","volume":"550","author":"J Huttunen","year":"2018","unstructured":"Huttunen J, Gynther M, Huttunen KM (2018) Targeted efflux transporter inhibitors - a solution to improve poor cellular accumulation of anti-cancer agents. Int J Pharm 550(1\u20132):278\u2013289. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.047","journal-title":"Int J Pharm"},{"key":"4506_CR197","doi-asserted-by":"publisher","unstructured":"Zhou ZY, Wang JY, Li ZX, et al. Branched-chain amino acids deficiency promotes diabetic neuropathic pain through upregulating LAT1 and inhibiting Kv1.2 channel. Adv Sci (Weinh). Published online July 1, 2024. https:\/\/doi.org\/10.1002\/advs.202402086","DOI":"10.1002\/advs.202402086"},{"key":"4506_CR198","doi-asserted-by":"publisher","unstructured":"Yanagiya R, Miyatake Y, Watanabe N, et al. Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia. Leukemia. https:\/\/doi.org\/10.1038\/s41375-024-02296-6","DOI":"10.1038\/s41375-024-02296-6"},{"key":"4506_CR199","doi-asserted-by":"publisher","unstructured":"Vamathevan J, Clark D, Czodrowski P, et al (2019) Applications of machine learning in drug discovery and development. Nat Rev Drug Discov\u00a018(6):463\u2013477. https:\/\/doi.org\/10.1038\/s41573-019-0024-5","DOI":"10.1038\/s41573-019-0024-5"},{"key":"4506_CR200","doi-asserted-by":"publisher","unstructured":"Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK (2021) Artificial intelligence in drug discovery and development.\u00a0Drug Discov Today 26(1):80\u201393. https:\/\/doi.org\/10.1016\/j.drudis.2020.10.010","DOI":"10.1016\/j.drudis.2020.10.010"},{"key":"4506_CR201","doi-asserted-by":"publisher","unstructured":"Gholap AD, Uddin MJ, Faiyazuddin M, Omri A, Gowri S, Khalid M (2024) Advances in artificial intelligence for drug delivery and development: A comprehensive review.\u00a0Comput Biol Med\u00a0178:108702. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108702","DOI":"10.1016\/j.compbiomed.2024.108702"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04506-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T01:06:12Z","timestamp":1738544772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04506-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":201,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["4506"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04506-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}